Search hospitals > Texas > Austin

Dell Children's Medical Center of Central Texas

Claim this profile
Austin, Texas 78723
Global Leader in Tumors
Global Leader in Leukemia
Conducts research for Lymphoma
Conducts research for Brain Tumor
Conducts research for Lymphoblastic Leukemia-Lymphoma
208 reported clinical trials
4 medical researchers
Photo of Dell Children's Medical Center of Central Texas in AustinPhoto of Dell Children's Medical Center of Central Texas in Austin

Summary

Dell Children's Medical Center of Central Texas is a medical facility located in Austin, Texas. This center is recognized for care of Tumors, Leukemia, Lymphoma, Brain Tumor, Lymphoblastic Leukemia-Lymphoma and other specialties. Dell Children's Medical Center of Central Texas is involved with conducting 208 clinical trials across 428 conditions. There are 4 research doctors associated with this hospital, such as Shannon M. Cohn, Brian Kaufman, MD, Jason Fulmer, MD, and Virgina Harrod, MD, PhD.

Area of expertise

1Tumors
Global Leader
Dell Children's Medical Center of Central Texas has run 46 trials for Tumors. Some of their research focus areas include:
Stage IV
Stage I
Stage II
2Leukemia
Global Leader
Dell Children's Medical Center of Central Texas has run 44 trials for Leukemia. Some of their research focus areas include:
Stage II
Philadelphia chromosome positive
NTRK1 positive

Top PIs

Clinical Trials running at Dell Children's Medical Center of Central Texas

Brain Tumor
Langerhans Cell Histiocytosis
Germ Cell Tumors
Osteosarcoma
Rhabdomyosarcoma
Non-Hodgkin's Lymphoma
Acute Lymphoblastic Leukemia
Astrocytoma
Acute Myeloid Leukemia
Neuroblastoma
Image of trial facility.

Selumetinib + Vinblastine

for Low-Grade Glioma

This phase III trial investigates the best dose of vinblastine in combination with selumetinib and the benefit of adding vinblastine to selumetinib compared to selumetinib alone in treating children and young adults with low-grade glioma (a common type of brain cancer) that has come back after prior treatment (recurrent) or does not respond to therapy (progressive). Selumetinib is a drug that works by blocking a protein that lets tumor cells grow without stopping. Vinblastine blocks cell growth by stopping cell division and may kill cancer cells. Giving selumetinib in combination with vinblastine may work better than selumetinib alone in treating recurrent or progressive low-grade glioma.
Recruiting2 awards Phase 339 criteria
Image of trial facility.

Selumetinib vs. Chemotherapy

for Brain Cancer

This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
Image of trial facility.

Selumetinib vs Carboplatin/Vincristine

for Brain Cancer

This phase III trial studies if selumetinib works just as well as the standard treatment with carboplatin/vincristine (CV) for subjects with NF1-associated low grade glioma (LGG), and to see if selumetinib is better than CV in improving vision in subjects with LGG of the optic pathway (vision nerves). Selumetinib is a drug that works by blocking some enzymes that low-grade glioma tumor cells need for their growth. This results in killing tumor cells. Drugs used as chemotherapy, such as carboplatin and vincristine, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. It is not yet known whether selumetinib works better in treating patients with NF1-associated low-grade glioma compared to standard therapy with carboplatin and vincristine.
Recruiting2 awards Phase 328 criteria

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Dell Children's Medical Center of Central Texas?
Dell Children's Medical Center of Central Texas is a medical facility located in Austin, Texas. This center is recognized for care of Tumors, Leukemia, Lymphoma, Brain Tumor, Lymphoblastic Leukemia-Lymphoma and other specialties. Dell Children's Medical Center of Central Texas is involved with conducting 208 clinical trials across 428 conditions. There are 4 research doctors associated with this hospital, such as Shannon M. Cohn, Brian Kaufman, MD, Jason Fulmer, MD, and Virgina Harrod, MD, PhD.